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. Candidate vaccines to prevent Ascaris infection should be able to trigger effective 48 antibody responses targeting essential antigens for the parasite to complete its life cycle (Harris 49 and Gause, 2011) . The challenge is, that these large, multicellular and cuticularized parasites 50 confront the host with a complex mixture of protein antigens from which we have still very poor 51 knowledge on their importance for infection or their immunogenicity. Ascaris parasites actively 52 excrete and secrete complex mixtures of molecules, Vic. the Excretory Secretory (ES) products, 53 which are essential in parasite's communication with its host, and shaping the host immune 54 response (Hewitson, Grainger and Maizels, 2009; Wang et al., 2013; Chehayeb et al., 2014) . The 55 ES proteins comprise critical targets for vaccination in animal models and are expected to bear 56 targets for vaccination in humans as well (reviewed in (Zhan et al., 2014) ). Intriguingly, a 57 considerable heterogeneity was observed in antibody profiles of human infected individuals 58 (Haswell-Elkins et al., 1989; Kennedy et al., 1990) , and work on animal models demonstrated the 59 Major Histocompatibility Complex of class II-control of Ascaris antibody repertoires (Tomlinson et 60 al., 1989; Kennedy, Fraser and Christie, 1991) . Thus, the deterministic nature of T-B cell 61 responses -which implies that antigen-specific B cells receive help from antigen-specific, 62 activated CD4 + Th cells -should contribute to define targets for the design of candidate subunit 63 vaccines. Therefore, identifying the epitopes that are involved in the host's natural CD4 + Th cell 64 responses is essential to understand, monitor or modulate adaptive immune mechanisms that 65 orchestrate Ascaris spp. expulsion. However, the high complexity of Ascaris ES products and the 66 polymorphic nature of Major Histocompatibility Complex of class II (MHCII) molecules represent 67 two major challenges to define immunogenic antigens for a majority of humans. 68 CD4 + Th cells recognize antigenic peptides presented by the major histocompatibility complex 69 class II (MHCII) proteins expressed on antigen-presenting cells (APC). Peptides from antigens 70 only become immunogenic when they are selected for presentation, and remain bound to MHCII 71 molecules for a sufficient time to allow T cell surveillance. Thus, the abundance of antigens, their 72 resistance to degradation and the affinity for the MHCII will define the potential immunogenicity 73 CD4 + Th immunogenicity of complex antigens 4 of any peptide. To date, conventional in silico approaches predict peptide-MHCII affinity mostly 74 based on MHC pocket occupation by the peptide amino acids (Lundegaard, Lund and Nielsen, 75 2012; Sanchez-Trincado, Gomez-Perosanz and Reche, 2017) . However, these approaches 76 ignore relevant aspects affecting epitope selection, such as the dynamics of peptide-MHCIIs 77 (Wieczorek et al., 2016 (Wieczorek et al., , 2017 (pMHCII), the peptide-editing function of HLA-DM (Álvaro-Benito 78 et al., 2014) , and the influence of proteolytic activities on antigen presentation (Kim and Sadegh-79 Nasseri, 2015) . Although integrating proteolytic degradation improves the current conventional 80 methods (Barra et al., 2018) , a robust in silico ranking of the most effectively presented peptides 81 is still elusive. Experimental approaches based on recombinant proteins or subcellular fractions 82 containing endosomal compartments rich on MHCII have been applied to define epitope selection 83 on single antigens (Hartman et al., 2010; Mutschlechner et al., 2010) . Culture of primary DC and 84 quantitative immunopeptidomics of infected cells has also been used to define CD4 + Th cell 85 epitopes from Listeria monocytogenes in mouse (Graham et al., 2018) . However, to date, there 86 is no experimental set up to define the CD4 + Th immunogenicity of complex antigenic mixtures in 87 humans. 88
Here, we introduce a bottom-up experimental approach to delineate the CD4 + Th 89 immunogenicity of Ascaris ES. As antigen source we used ES from Ascaris suum, the closely 90 related porcine analogue of A. lumbricoides, which is considered antigenically identical. Initially, 91
we performed a proteomic characterization of male and female parasite ES (ESM and ESF 92 respectively) products (Wang et al., 2013; Chehayeb et al., 2014) to define the antigens bearing 93 potential CD4 + Th epitopes ( Fig.1A) . By combining the use of the exponentially modified Protein 94 Abundance Index (emPAI) with 16 O/ 18 O-labelling we defined the ESM and ESF composition, 95 thereby retrieving absolute protein abundances of ESM and ESF extracts ( Fig. 1B left) , and the 96 relative difference between them ( Fig. 1B right) . This analysis yielded additional information 97 regarding the differences in abundance between ESF and ESM (Table S1) in comparison to the 98 previously described dataset (Chehayeb et al., 2014) . The difference in the number of protein 99 sources found here when compared with the previous study (175 previously vs. 254 in our case) 100 arises from our conservative approach when considering the source of tryptic peptides. Rather 101 than selecting a single leading protein, we explicitly kept protein entries with small differences in 102 their primary sequences but which are not clearly distinguishable by conventional shotgun MS. 103
This characterization provides a detailed overview of the potential antigenic sources of CD4 + Th 104 cell epitopes. We found large differences in the abundance of proteins either within a single extract 105 or between ESM and ESF (fold-differences up to 10 3 for emPAI and 10 7 , respectively). We 106 CD4 + Th immunogenicity of complex antigens 5 annotated all entries according to the defined absolute and relative abundance to further evaluate 107 whether protein abundance is a key factor defining the immunogenicity of ES proteins. 108
We then hypothesized that the potential CD4 + Th epitopes of Ascaris secreted products could 109 be experimentally defined by combining key events of HLA-specific antigen presentation as 110 described by the minimalist approach of Sadegh-Nasseri's group (Hartman et al., 2010) . Using 111 this system, the lower background of self-peptides will benefit the MS identification of pathogen 112 derived antigenic peptides. We applied the ESM or ESF antigens, two common MHCII allotypes 113
in Ascaris-endemic territories (DRB1*07:01 or DRB1*15:01, see Fig. S1A ) preloaded with the 114 placeholder Class II invariant chain peptide-CLIP and HLA-DM, which functions as peptide-editor 115 (Álvaro-Benito et al., 2014) (details in Fig. S1B ) and the commercial proteases previously 116 described (Hartman et al., 2010) . To evaluate the impact of protein composition on epitope 117 selection the distinct antigen profiles of ESF and ESM were used. Control experiments confirmed 118 that ES antigens are degraded by cathepsins while MHCII are resistant ( Fig. 1D ). 119
Immunoprecipitation of HLA-DR molecules and treatment with TFA yielded the pool of bound 120 peptides for each condition, which were further analyzed by LC-ESI-MS. We used MaxQuant for 121 peptide identification considering a customized database that includes all the entries found in the 122 ES products and the molecules of the in vitro reconstitution system (MHCII, HLA-DM and 123 proteases). The information on MS1 intensity for each identified peptide ( Fig. 1E ) was used by 124 our recently described epitope analysis tool, PLAtEAU (Álvaro-Benito et al., 2018) , to define 125 consensus peptides including their relative abundance for each series of peptides that contain a 126 common core but vary in the length of their N-and C-terminal extensions (Fig. 1F ). The full list of 127 335 potential of CD4 + T cell epitopes was annotated based on the abundance of the 128 corresponding protein source and the predicted affinity for each allotype (Table S2) . 129
Our experimental workflow leads to a massive reduction in the number of potential epitopes 130 from a total of 2 x 10 5 potential 15-mer peptides in the whole ES protein extract, to less than 10 3 131 peptides, which once analyzed with PLAtEAU resulted in around 150 candidate epitopes for each 132 condition (details given in Fig. S1B ). Furthermore, the presence of predicted weak and high affinity 133 binders increases from 10% and 1 % in the pool of all potential peptides of the ES to 20 % and 134 7% in the experimentally determined peptides, respectively (details given in Fig. S1B ). Surely, the 135 inclusion of HLA-DM in the system is a major driver for the focusing of the repertoire as it is seen 136 here ( Fig. 1G ). Hierarchical clustering analysis of the annotated potential epitopes based on their 137 abundance reveals that both MHCII molecules selected mostly epitopes from proteins with 138 intermediate and high emPAI values, and in particular from those enriched (e.g. ESF:ESM ratio 139 > 2) in the respective antigen source (ESM or ESF) ( Fig. 1H ). Mapping the intensities to their 140 CD4 + Th immunogenicity of complex antigens 6 sources in the volcano plots depicting the compositional overview of the ES confirmed the result 141 ( Fig. 1I and S1C). Most interestingly, we found the Ov1743-64 consensus peptide as a prime 142 candidate to test its potential immunogenicity for two main reasons. First, this peptide it is selected 143 exclusively under DRB1*07:01 + ESF conditions, thereby representing an ideal candidate to 144 prove the selectivity and performance of our experimental approach. Second, experiments on 145 swine and mouse models have shown the potential of Ov17 antigen (also referred to as As16) for 146 conferring protection to Ascaris suum infection (Tsuji et al., 2003 (Tsuji et al., , 2004 , and for eliciting Th2-type 147 responses (Wei et al., 2017) indicating its interpecies immunogenicity. Furthermore, in humans, 148 the restricting DRB1*07:01 allele reaches up to 9 % of the global population (Gourraud et al., 149 2014 ) and even higher frequencies on Ascaris lumbricoides endemic areas with up to 15 % in 150 specific African and Asian populations. 151
We were interested in validating whether the Ov1743-67 candidate is recognized as a human 152 T cell epitope, and evaluating the performance of the reconstituted in vitro system, by applying 153 the TcR pool present in healthy individuals to a limited set of candidates. Our restricted set of 154 candidates includes one peptide with a similar affinity for DRB1*07:01 but not selected from the 155 ESF antigen (U1MRA1601-620), a peptide (PABA1305-324) that belongs to the immunogenic 156 Polyprotein ABA1 (Kennedy, Fraser and Christie, 1991; Kennedy et al., 2008) , and a peptide 157 (RtBP25-45) not selected by this allotype. Thus, out of the four peptides chosen (Fig. 1J ), only 158 OV1743-62, should be selected for presentation from ESF antigen, and therefore elicit T cell 159 responses when presented by DRB1*07:01. We generated human T cell lines from healthy 160 volunteers reactive against the whole ESF antigen using antigen-specific T cell enrichment and 161 expansion as described by Bacher et al. (Bacher et al., 2013) (Fig. 2A ). This approach is based 162 on the up-regulation of CD40-L shortly after TcR-mediated antigen recognition irrespectively of 163 the restricting MHC allele and can be used to assess and enrich antigen-specific T cells (Bacher 164 and Scheffold, 2015) . In our case, it helped us to overcome the expected low in vivo frequency of 165 any potential Ascaris ESF-specific CD4 + Th cells in healthy (uninfected) donors, as confirmed by 166 CD40-L staining following ES antigenic stimulation ( Fig. 2B ). Indeed, a considerable amount of 167 CD40-L + cells (mean  SEM: 33.8 %  5.3 among CD4 + T cells) resulted from re-stimulation of 168 enriched and expanded human cells with Ascaris ESF antigen loaded to APCs compared to 169 unloaded autologous APCs ( Fig. 2C and 2D ). This refers to the population of total ES-reactive 170 CD4 + Th cells of different donors after expansion. Upregulation of CD40-L and CD40-L/cytokine 171 co-expression after re-stimulation confirms a functional CD4 + Th phenotype of the generated cell 172 lines ( Fig. S2) . 173
CD4 + Th immunogenicity of complex antigens 7 Furthermore, we derived ESF T cell lines from a healthy, DRB1*03:01;07:01-typed volunteer 174 and assessed CD40-L expression after re-stimulation with either whole antigen, the selected pool 175 of four peptides, or single peptide loaded APCs ( Fig. 2E ). Strikingly, we found that the Ov1743-62, 176 the only candidate selected as potential CD4 + Th cell epitope by our approach with predicted high 177 affinity, yield a stronger T cell response than any of the other peptides assayed (Fig. 2F ). These 178 results therefore confirm the predictive power of the reconstituted in vitro system. Indeed, the 179 combination of all peptides as well as only the single peptide Ov1743-62 generated a CD40-L 180 response above the background (shown as a dashed line). 181
We reasoned that we could derive a parameter to define the potential immunogenicity (pIm) 182 of all experimentally defined epitopes based on their measured abundance. This parameter 183 reflects the ratio between the absolute value of the log2 MS1 intensity for the epitope (lower for 184 high abundant) and the 1-logKaff value as its predicted affinity (increases with higher affinity). 185
Thus, the lower the pIm value for a candidate, the higher the likelihood to be immunogenic as 186 indeed is reflected for the pool of potential epitopes selected ( Fig. 2G ). Indeed, for the two 187 candidates found in DRB1*07:01 + ESF, the pIm value reflects the abundance of T cells reactive 188 after expansion with the whole ESF. 189
Considering the co-dominant expression of other HLA genes in the donor-derived cell lines, 190 the reactivity observed could arise from the presentation of the corresponding peptides by any 191 other donor-MHCII allotype. We confirmed the DRB1*07:01 restriction for the presentation of the 192 Ov17 peptide by tetramer staining of ESF CD4 + T cell lines. A significant pool of CD4 + T cells 193 responding to this peptide is detected when it is displayed by DRB1*07:01 tetramers compared 194 to control tetramers (DR7CLIP or DR7RtBP25-44 tetramers; Fig. 2H ). Of note, the overall low frequency 195 of DRB1*07:01-TetOv17 + cells can be explained by the low frequency of whole antigen-reactive T 196 cells for the cell line applied in that assay (only 6.9% CD40-L + , Fig. 2G ), but still reflect that 2.8% 197 of all ESF reactive T cells bind DRB1*07: Together, we demonstrate that a reduced set of in vitro and ex vivo experiments is extremely 199 useful to define human CD4 + Th cell epitopes from complex antigenic mixtures bypassing the need 200 of animal models (Walsh et al., 2017) or immunization in humans (Gilchuk et al., 2013) . show its restriction by the DRB1*07:01 allotype. Immunization with this antigen in animal trials 208 elicits considerable protective immunity to Ascaris suum including specific antibodies and Th2-209 type cytokine responses (Tsuji et al., 2003 (Tsuji et al., , 2004 Wei et al., 2017) . It will thus be of great 210 importance to further characterize immune responses against the Ov17/As16 antigen in other 211 MHCII allotypes to define its potential for vaccination. Another interesting candidate for instance 212 is PABA1 (Kennedy et al., 2008) , showing a completely different peptide selection pattern for the 213 two alleles used, with a considerably higher number of consensus peptides selected by 214 DRB1*15:01 when compared to DRB1*07:01 (7 vs. 1 respectively). Prospectively, the stage is 215 then set to investigate a pooled, yet limited number of antigens to profile the T cell immune status 267 219-24. doi: 10.1111/j.1365-2249.1990.tb05237.x. 
Materials and methods

307
Antigen preparation 308
Excretory-secretory (ES) antigens were prepared from worm culture supernatants of male 309 and female adult Ascaris suum worms obtained from a local slaughter house. In brief, worms 310 were separated by sex and washed several times in a balanced salt solution (BSS) containing 311 antibiotics and used as culture media for adult worms (127 mM NaCl, 7.5 mM NaHCO3, 5 mM 312
KCl, 1 mM CaCl2, 1 mM MgCl2, 200 U/mL penicillin, 200 μg/mL streptomycin, 50 μg/mL 313 gentamicin, 2.5 μg/mL amphotericin B) and kept at 37°C with 5% CO2. Media was replaced on a 314 daily basis, sterile filtered through a 0.22 μM vacuum-driven filter system and collected for ES 315 antigen preparations starting 48h after beginning of worm culture and finally stored at -20°C until 316 further use. Worm culture supernatants collected over 1 week were further concentrated using 317 centrifugal protein concentrators with a 5 kDa MWCO (Vivaspin, Sartorius, Göttingen, Germany) 318 to obtain the final, concentrated ESF antigen (from female worms) and ESM (from male worms). 319
Mass spectrometry 320
Peptide mixtures were analyzed by a reversed-phase capillary system (Ultimate 3000 321 nanoLC) connected to an Orbitrap Velos (Thermo Fischer) using conditions and settings 322 described previously (Álvaro-Benito et al., 2018) . 323
For quantitative proteomics, we used 16 and -DR7, as well as HLA-DM. No enzyme specificity was used for the search, and a tolerance 341 of 10 ppm was allowed for the main ion search and 50 ppm for the MSMS identification The 342 "match between runs" feature was enabled. The FDR was set at 0.01 (1 %). Reverse IDs and 343 known contaminants like keratins were filtered before further data analysis. Raw files and 344 processed data is available upon request and will be deposited in the PRIDE repository. 345
Bioinformatics prediction of MHCII binding 346
NetMHCIIPan 3.2 was used to predict peptide binding to the indicated HLA-DR allotypes. 347
The protein database generated upon the MS analysis (only quantified proteins) was loaded into 348 the webserver using a 2 percent and 10 percent cutoff for strong and weak binders. 349
Constructs, protein expression and purification 350
DNA constructs encoding HLA molecules used in this study have been generated 351 according to the sequences available in the IMGT/HLA database 352 (http://www.ebi.ac.uk/ipd/imgt/hla/). The cDNAs encoding the different HLA subunits were cloned 353 into the pFastBacDual. Recombinant proteins were expressed in Sf9 cells infected at an MOI of 354 5 for 72 h. Supernatants were treated as previously reported to purify the target proteins by 355 immunoaffinity chromatography using anti-HLA-DR-FF-sepharose or M2 anti flag (Sigma) (Álvaro-356 Benito et al., 2014) . 357
Depending on the application, HLA-DR molecules were further treated prior to their use with only 358
Thrombin (20 U/mg protein; for tetramer preparation) or with Thrombin and V8 protease (10 U/mg; 359 in vitro reconstituted system) for 2 h at 37 °C. Subsequently proteases were inactivated by adding 360
Complete protease inhibitor cocktail (Roche) and further gel-filtrated, while HLA-DM proteins were 361 directly subjected to gel filtration. Both types of HLA proteins were gel-filtrated in a Sephadex 362 S200. Fractions containing the proteins of interest were pooled and concentrated with Vivaspin 363 10 KDa MWCO spin filter. 364
Peptide selection and synthesis 365
The complete list of peptides obtained after PLAtEAU analysis for all experiments was 366 loaded into excel as a single list. We used the excel random selection function to generate a list 367 of 4 peptides from the whole dataset. The corresponding sets of 4 peptides (500 iterations) were 368 screened to define those with two peptides originating from the same antigen (ESF or ESM) and 369 found in one set of experiments (DRB*01:07 or DRB*15:01). An additional criteria included the 370 presence on the set of 4 peptides of at least one peptide not found in the corresponding 371 experiment (used as control). The corresponding list of peptides indicated arises as the one 372 fulfilling these criteria and having the larger distance between pIm values. Synthetic peptides were 373 subsequently purchased from Peptides and Elephants (Berlin, Germany). Purity as stated by the vendor was more than 95 %. All peptides were protected in their N-and C-termini by addition of 375 a Ac and NH2 group respectively. 376
In vitro reconstituted antigen processing system 377
The previously described cell-free reconstituted in vitro system (Hartman et al., 2010) was 378 modified according to the specific needs of the experiments. HLA molecules together with the 379 candidate antigens and HLA-DM were incubated for 2 h at 37° C in citrate phosphate 50 mM pH 380 5.2 in the presence of 150 mM NaCl. Cathepsins were added to reaction mixtures after incubation 381 with L-Cysteine (6 mM) and EDTA (5 mM). Cathepsin B (Enzo), H (Enzo), L (Enzo) and S (Sigma) 382
were used for our in vitro experiments at molar ratios (cathepsin:substrate) ranging from 1:250 to 383 1:500. The final reaction mixture was incubated at 37° C for 2 to 5 hours. Afterwards the pH was 384 adjusted to 7.5 and Iodoacetamide was added (25 M). Immunoprecipitation (IP) of the pMHCII 385 complexes was performed using L243 covalently linked to Fast Flow sepharose. Peptides were 386 eluted from purified MHCII adding TFA 0.1% to the samples. Peptides were separated from the 387 MHCII molecules by using Vivaspin filters (10kDa MWCO) and a subsequent reverse phase C18 388 enrichment. The filtrates were further lyophilized and resuspended for mass spectrometry 389 analyses in a mixture of H2O (0.94):AcN (0.05): TFA (0.01). 390
Cell isolation and stimulation 391
Permission for experiments with human primary cells with the consent of healthy donors 392 was obtained from the local ethic committee. Peripheral blood mononuclear cells (PBMC) were 393 isolated by density gradient centrifugation over human Pancoll (1.077 g/ml, 394 Aidenbach, Germany) and rested over-night in serum-free RPMI-1640 supplemented with 395 100 U/ml penicillin and 100 µg/ml streptomycin (all from PAN-Biotech, Aidenbach, Germany). For 396 enrichment, 2 x 10 7 PBMC/ml/well were stimulated for 6h with excretory-secretory antigen 397 mixtures of female Ascaris suum worms (ESF, 40 µg/ml) in the presence of anti-CD40 (clone 398 HB14, 1 µg/ml functional grade pur, Miltenyi Biotec, Bergisch Gladbach, Germany) and anti-CD28 399 (clone CD28.2, 1 µg/ml, BD Pharmingen TM , NJ, US). Following stimulation, antigen-specific T cells 400 were separated using the CD154 MicroBead Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) 401 according to the manufacturer's suggestions. That included labeling first with CD154-biotin and 402 magnetically anti-biotin microbeads in a second step followed by enrichment using MS MACS 403 columns (Miltenyi Biotec, Bergisch Gladbach, Germany). 404
For assessing precursor frequencies of Ascaris ESF specific CD4 + T cells, PBMC were 405 stimulated as described above and Brefeldin A (3 µg/ml, Thermo Fisher Scientific) was added 406 after the first 2h of stimulation before intracellular staining for CD40-L. 407 
Generation of Ascaris suum ES antigen-specific T cell lines and restimulation
